– Fox Business Report
Virios Therapeutics Shares Almost Double In Trading Session – Here’s Why
Virios Therapeutics Inc (NASDAQ:VIRI) announced a program summary based on initial feedback from the FDA on its Phase 3 FM program…
Related Posts
New Leak Reiterates Apple’s iPhone 15 Pro Models Could Get RAM Boost to 8GB, But This Crucial Choice Remains Unchanged
Apple iPhone 15 Pro models are expected to feature a potential upgrade to 8GB RAM, but will reportedly maintain current storage options without introducing a 2TB variant.
SciSparc Granted Patent From The Australian Patent Office For Its Reduction Of Opioids Use In Pain Management Technology
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,
Methode Electronics, Inc. Announces Preliminary Financial Results For Fiscal 2023; Sees FY23 Revenue $1.183B Vs $1.17B Est.; EPS $2.10-$2.14 Vs $2.51 Est.
Preliminary Financial Results for Fiscal 2023The company expects to report record net sales of approximately $1,183 million for fiscal 2023, which would represent a two percent increase from the prior fiscal year. This